<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>Industry</th>
      <th>GRI Code</th>
      <th>GRI Name</th>
      <th>Disclosure</th>
      <th>Disclosure Name</th>
      <th>General Information</th>
      <th>Initiative</th>
      <th>Initiative from the undisclosed GRI (found by the coder but not mentioned in the GRI index table)</th>
      <th>UNDISCLOSED GRI</th>
      <th>Organisation</th>
      <th>Year</th>
      <th>Solution Description</th>
      <th>Solution Outcome</th>
      <th>Digital tool</th>
      <th>Data Source</th>
      <th>Unnamed: 15</th>
      <th>Unnamed: 16</th>
      <th>Unnamed: 17</th>
      <th>Keywords</th>
      <th>SDGs</th>
      <th>ESG</th>
      <th>UNGC</th>
      <th>Notes</th>
      <th>Unnamed: 23</th>
      <th>Unnamed: 24</th>
      <th>Unnamed: 25</th>
      <th>Unnamed: 26</th>
      <th>Unnamed: 27</th>
      <th>Unnamed: 28</th>
      <th>Unnamed: 29</th>
      <th>Unnamed: 30</th>
      <th>Unnamed: 31</th>
      <th>Unnamed: 32</th>
      <th>Unnamed: 33</th>
      <th>Unnamed: 34</th>
      <th>Unnamed: 35</th>
      <th>Unnamed: 36</th>
      <th>Unnamed: 37</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>GRI Index</td>
      <td>SR</td>
      <td>AR</td>
      <td>CGS</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-1</td>
      <td>Organizational details</td>
      <td>PME is a developer and supplier of healthcare imaging software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, North America and Europe.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>11</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-2</td>
      <td>Entities included in the organization's sustainability reporting</td>
      <td>Pro Medicus Limited is an Australian incorporated and domiciled company listed on the ASX with subsidiaries in Europe and North America (collectively the Group).</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>11</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-3</td>
      <td>Reporting period, frequency, and contact point</td>
      <td>This report covers Pro Medicus' operations with information referring to the year ended 30 June 2023 unless otherwise stated. It includes the critical disclosures required under Australian legislation and provides a holistic business overview.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>1</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-4</td>
      <td>Restatements of information</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-5</td>
      <td>External assurance</td>
      <td>Pro Medicus has an Audit and Risk Management Committee tasked with verifying the integrity of any periodic corporate report released to the market that has yet to be audited or reviewed by the Company's external auditor, EY.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>1</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-6</td>
      <td>Activities, value chain and other business relationships</td>
      <td>The principal activities of the Group during the year were the development and supply of healthcare imaging software, Radiology Information System (RIS) software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, North America and Europe.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>11</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-7</td>
      <td>Employees</td>
      <td>Number of Employees - 110</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>5</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Modern slavery statement</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-8</td>
      <td>Workers who are not employees</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-9</td>
      <td>Governance structure and composition</td>
      <td>As of 30 June 2023, the Company had an Audit and Risk Committee comprising 5 Non-Executive Directors and a People and Culture Committee comprising 4 Non-Executive Directors.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>26</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-10</td>
      <td>Nomination and selection of the highest governance body</td>
      <td>When considering the appointment of directors to the Board, a formal process is undertaken to identify various candidates, with interviews held and appropriate background checks carried out. In addition, the Board considers and formally resolves to support the election or re-election of directors to shareholders at general meetings/annual general meetings. Before director candidates are selected, the Board considers the current collective skills and competencies. It assesses its needs at that time and into the future and develops selection criteria for the candidates.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>7</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-11</td>
      <td>Chair of the highest governance body</td>
      <td>Peter Kempen joined Pro Medicus Limited as a Director on 12 March 2008. He is Chairman of Australasian Leukemia and Lymphoma Group. He is also a Trustee of the Barr Family Foundation and a member of the Board of St Hilda's College Ltd, University of Melbourne member. Peter became Chairman in August 2010 before serving as the Company's Non-Executive Director.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>24</td>
      <td>6</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-12</td>
      <td>Role of the highest governance body in overseeing the management of impacts</td>
      <td>The Board is responsible for the overall operation and stewardship of the Company and, in particular, for the long-term growth and profitability of the Company's strategies, values, policies and financial objectives, including the responsibilities set out below. The Board is also responsible for overseeing management in implementing the Company's policies, strategies and economic goals and instilling the Company's values.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>1</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Board Charter</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-13</td>
      <td>Delegation of responsibility for managing impacts</td>
      <td>Each of these committees operates by specific charters approved by our Board, which sets out its composition, functions and responsibilities. In addition, our Board may establish ad-hoc committees or delegate authority to existing committees to oversee specific activities.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>11</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-14</td>
      <td>Role of the highest governance body in sustainability reporting</td>
      <td>Identifying the principal risks of the Company's business and reviewing the Company's risk management framework at least annually to ensure that the Company has in place an appropriate risk management framework, which may include economic, environmental and social sustainability risks, operational, financial, non-financial and strategic risks, and contemporary and emerging risks such as conduct risk, digital disruption, cyber-security, privacy and data breaches, sustainability and climate change.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>1</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Board Charter</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-15</td>
      <td>Conflict of interest</td>
      <td>Our non-executive directors are appointed under formal letters of appointment, which, among other things, set out the key terms and conditions of the appointment, the Board's expectations about the performance of the director, procedures for dealing with a director's potential conflict of interest and the disclosure obligations of the director, together with the details of the director's remuneration. All senior executives are direct reports to the CEO and have detailed service contracts in place, with performance criteria requirements for short- and long-term incentives outlined in incentive offer documents provided to them annually.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>13</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-16</td>
      <td>Communication of critical concerns</td>
      <td>NaN</td>
      <td>Disclosure and Communication Policy</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>We have adopted a Disclosure and Communication Policy, the objectives of which are to ensure that the Company can meet its continuous disclosure obligations under the ASX Listing Rules and the Corporations Act and establish internal procedures so that all Group Personnel understand their obligations to ensure confidential information is protected and disclosure of price sensitive information to the Disclosure Officer.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>19</td>
      <td>Disclosure, Communication, Policy</td>
      <td>16.0</td>
      <td>G</td>
      <td>13.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-16</td>
      <td>Communication of critical concerns</td>
      <td>NaN</td>
      <td>Shareholder communications policy</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>We are committed to maintaining direct, open, timely and effective two-way communications with all shareholders. Our policy is that shareholders are informed of all material developments that impact the Company.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>19</td>
      <td>Shareholders, Communication, Commitment</td>
      <td>16.0</td>
      <td>G</td>
      <td>13.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-17</td>
      <td>Collective knowledge of the highest governance body</td>
      <td>In establishing the Board Skills Matrix, the Board identified that, collectively, the Board does have the necessary mix of skills and experience appropriate to the current size and complexity of the Company's business. However, several emerging areas were identified where there are skills gaps, and the Board is supplementing their collective skillset with external advisors who are experts in these areas.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>7</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-18</td>
      <td>Evaluation of the performance of the highest governance body</td>
      <td>In FY23, we implemented a framework for a more structured annual assessment of the performance of the CEO and all senior executives. The evaluation is linked to individual goals and our corporate values. Under the framework, the Board assesses the CEO's performance and behaviour. In contrast, the CEO assesses the performance and behaviour of each of his direct reports and makes recommendations to the Board on their performance and remuneration.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>13</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-19</td>
      <td>Remuneration policies</td>
      <td>NaN</td>
      <td>Total fixed remuneration approach</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Base salary and retirement benefits (superannuation or country equivalent). May include fringe benefits or other payment methods provided that it is appropriate and reasonable for the Group.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>32</td>
      <td>NaN</td>
      <td>Salary, Retirement Benefits, Fringe</td>
      <td>8.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-19</td>
      <td>Remuneration policies</td>
      <td>NaN</td>
      <td>Short-term incentive (STI)</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>An at-risk component is set as a percentage of the base salary for senior executives. Performance is measured over the 12 months, and awards are made annually in cash.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>32</td>
      <td>NaN</td>
      <td>At-risk Component, Senior Executives, Performance</td>
      <td>8.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-19</td>
      <td>Remuneration policies</td>
      <td>NaN</td>
      <td>Long-term incentive (LTI)</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>This explains performance rights with a nil exercise price, issued annually based on a three-year performance period and a further 12-month vesting period.\t</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>32</td>
      <td>NaN</td>
      <td>Performance Rights, Exercise Price, Incentive</td>
      <td>8.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>The Company will continue to direct resources into the development of new products and is committed to the continued development of its Visage RIS and Visage 7 product sets. It is anticipated that this strategy of ongoing development will continue to position Pro Medicus as a market leader and enable the Group to further leverage its expanded product portfolio and geographical spread.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-20</td>
      <td>Process to determine remuneration</td>
      <td>The People and Culture Committee of the Board provides advice, assistance and recommendations to the Board about remuneration arrangements for Directors and Executives, as well as to advise and support the Board's oversight of critical people practices, such as succession planning and talent management, to help achieve the Company's long-term business objectives.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>31</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-21</td>
      <td>Annual total compensation ratio</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-22</td>
      <td>Statement on sustainable development strategy</td>
      <td>Sustainable and responsible business practices are essential to creating value for our employees, residents, suppliers, shareholders, and the community and environment. Updates on our commitments, activities, and progress about ESG matters will be disclosed in our Annual Report on an ongoing basis. In 2023, we continued to focus on ESG-related matters; this included preparatory work for reporting on our Modern Slavery obligations.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>18</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-23</td>
      <td>Policy commitments</td>
      <td>We are committed to providing well-supported, stable products and services to our customers, enabling them to improve workflow and diagnoses and ultimately providing more efficient patient care.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>1</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-23</td>
      <td>Policy commitments</td>
      <td>We are committed to continuous improvement of our systems, products and services.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>1</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-23</td>
      <td>Policy commitments</td>
      <td>We are committed to reducing our carbon emissions. Becoming carbon neutral involves reducing your carbon footprint and offsetting the remaining emissions to achieve a net-zero carbon balance.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-24</td>
      <td>Embedding policy commitments</td>
      <td>The Company is committed to creating and ensuring a work environment in which everyone is treated fairly and with respect and where everyone feels responsible for the reputation and performance of the Company. The Company's Board of Directors and Management believe that Pro Medicus' commitment to this policy embeds the importance and value of diversity within the Company's culture and contributes to the achievement of corporate objectives.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-24</td>
      <td>Embedding policy commitments</td>
      <td>The Company will continue to direct resources into developing new products and is committed to the continued growth of its Visage RIS and Visage 7 product sets. It is anticipated that this ongoing development strategy will continue to position Pro Medicus as a market leader and enable the Group to leverage its expanded product portfolio and geographical spread further.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>28</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-24</td>
      <td>Embedding policy commitments</td>
      <td>The Group remains committed to providing staff with access to appropriate training and development programs and the resources to complete their duties.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>28</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-25</td>
      <td>Processes to remediate negative impacts</td>
      <td>Our Group Code of Conduct (the Code) is designed to promote and set the standard of behaviour expected of the Board and our employees. The Code provides general guidance on the standards of work performance, ethical standards and behaviour required in line with our culture and values. The purpose of the Code is to set out the values, commitments, moral standards and policies of the Company and outline the standards of conduct expected of our business and people, taking into account the Company's legal and other obligations to its stakeholders.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-26</td>
      <td>Mechanisms for seeking advice and raising concern</td>
      <td>NaN</td>
      <td>Whistleblower Protection Policy</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>We have adopted a Whistleblower Protection Policy, the purpose of which is to allow people who are concerned about any improper conduct to feel comfortable reporting that conduct. It enables reporting dishonest, fraudulent, illegal, or otherwise inappropriate behaviour by employees, contractors, partners, former employees, and other relevant stakeholders.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>18</td>
      <td>Whistleblower, Protection, Policy</td>
      <td>16.0</td>
      <td>S</td>
      <td>16.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-27</td>
      <td>Compliance with laws and regulations</td>
      <td>Our governance policies and practices have been measured against the 4th edition of the ASX Corporate Governance Council's Corporate Governance Principles and Recommendations (ASX Governance Principles).</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>39</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-28</td>
      <td>Membership associations</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-29</td>
      <td>Approach to stakeholder engagement</td>
      <td>The Board will continue to engage with critical stakeholders, consult with them on matters that interest and impact them, and add to our Annual Report when necessary. We will also continue capturing their views during our regular business engagements.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>1</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>2.0</td>
      <td>General Disclosures</td>
      <td>2-30</td>
      <td>Collective bargaining agreements</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>3.0</td>
      <td>Material Topics</td>
      <td>3-1</td>
      <td>Process to determine material topics</td>
      <td>The Board and management team maintain high standards of corporate governance as part of our commitment to create value for our stakeholders through effective strategic planning, risk management, transparency, and corporate responsibility. We regularly review our governance practices in light of the Company's growth and relevant emerging corporate governance developments.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>39</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>3.0</td>
      <td>Material Topics</td>
      <td>3-2</td>
      <td>List of material topics</td>
      <td>People, Climate, Responsible AI</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>3.0</td>
      <td>Material Topics</td>
      <td>3-3</td>
      <td>Management of material topics</td>
      <td>NaN</td>
      <td>Risk Management Framework</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Our Audit and Risk Management Committee has been tasked with reviewing and assessing the Company's risk management framework at least annually. This process includes reviewing the implementation, management, and maintenance of appropriate enterprise-wide risk management systems, policies and procedures, reporting protocols, and internal controls to ensure they continue to be sound and that the Company is operating in line with the current risk appetite set by the Board.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>15</td>
      <td>NaN</td>
      <td>Audit, Risk Management, Committee</td>
      <td>9.0</td>
      <td>S</td>
      <td>12.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>3.0</td>
      <td>Material Topics</td>
      <td>3-3</td>
      <td>Management of material topics</td>
      <td>NaN</td>
      <td>Succession planning</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>The People and Culture Committee has identified the risk of a succession of critical executives following a strategic HR review to ensure that we have the right people in the right roles in the Company to continue its growth and success. Our succession planning framework helps us identify and develop talent who can move into leadership roles when they become vacant to ensure that as leadership changes, the Company maintains its productivity and continues to thrive.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17</td>
      <td>NaN</td>
      <td>People, Culture, Committee</td>
      <td>9.0</td>
      <td>S</td>
      <td>12.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>3.0</td>
      <td>Material Topics</td>
      <td>3-3</td>
      <td>Management of material topics</td>
      <td>NaN</td>
      <td>Inclusive workplace</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>We actively value and embrace the diversity of our employees and are committed to creating an inclusive workplace where everyone is treated equally and fairly and where discrimination, harassment and inequity are not tolerated. While we are dedicated to fostering diversity at all levels, gender diversity has been and continues to be a priority for the Company.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>14</td>
      <td>Diversity, Inclusive Workplace, employees</td>
      <td>5.0</td>
      <td>S</td>
      <td>10.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>201.0</td>
      <td>Economic Performance</td>
      <td>201-01</td>
      <td>Direct economic value generated and distributed</td>
      <td>Reported profit after tax for the period was $60.65m, an increase of 36.5% from the previous year.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>5</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>201.0</td>
      <td>Economic Performance</td>
      <td>201-01</td>
      <td>Direct economic value generated and distributed</td>
      <td>Won seven key contracts in North America and renewed another contract in North America.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>5</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>201.0</td>
      <td>Economic Performance</td>
      <td>201-01</td>
      <td>Direct economic value generated and distributed</td>
      <td>Total contracted revenue increase to $468m over the next 5 years</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>5</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>201.0</td>
      <td>Economic Performance</td>
      <td>201-02</td>
      <td>Financial implications and other risks and opportunities due to climate change</td>
      <td>NaN</td>
      <td>Carbon offset projects</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>We invest in verified carbon offset projects to offset the remaining emissions we cannot eliminate through the above measures.\t</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17, 22</td>
      <td>NaN</td>
      <td>Carbon Offset, Emissions, Investment</td>
      <td>13.0</td>
      <td>E</td>
      <td>13.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>201.0</td>
      <td>Economic Performance</td>
      <td>201-03</td>
      <td>Defined benefit plan obligations and other retirement plans</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>201.0</td>
      <td>Economic Performance</td>
      <td>201-04</td>
      <td>Financial assistance received from government</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>202.0</td>
      <td>Market Presence</td>
      <td>202-01</td>
      <td>Ratios of standard entry level wage by gender compared to local minimum wage</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>202.0</td>
      <td>Market Presence</td>
      <td>202-02</td>
      <td>Proportion of senior management hired from the local community</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>203.0</td>
      <td>Indirect Economic Impacts</td>
      <td>203-01</td>
      <td>Infrastructure investments and services supported</td>
      <td>NaN</td>
      <td>Visage RIS</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>It is a proprietary medical software for practice management, training, installation and professional services, after-sale support and service products, Promedicus.net secure email and Integration products.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>11</td>
      <td>NaN</td>
      <td>Medical Software, Practice Management, products</td>
      <td>3.0</td>
      <td>S</td>
      <td>10.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>203.0</td>
      <td>Indirect Economic Impacts</td>
      <td>203-01</td>
      <td>Infrastructure investments and services supported</td>
      <td>NaN</td>
      <td>Visage 7</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>It is a healthcare imaging software that provides radiologists and clinicians with advanced visualisation capability for rapidly viewing 2-D, 3-D and 4-D medical images. This Picture Archive and Communication System (PACS)/Digital Imaging software is sold directly to original equipment manufacturers (OEM), training, installation, professional services, and support products.\t</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>11</td>
      <td>NaN</td>
      <td>Healthcare Imaging, Radiologists, Software</td>
      <td>3.0</td>
      <td>S</td>
      <td>10.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>203.0</td>
      <td>Indirect Economic Impacts</td>
      <td>203-01</td>
      <td>Infrastructure investments and services supported</td>
      <td>NaN</td>
      <td>Visage CloudPACS™</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>The Company's cloud-native solution, Visage CloudPACS™, enables customers to avail themselves of the scalability and security of public cloud infrastructure – a trend gaining significant momentum in the healthcare industry.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>11</td>
      <td>NaN</td>
      <td>Cloud Solution, Scalability, Security</td>
      <td>3.0</td>
      <td>S</td>
      <td>10.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>203.0</td>
      <td>Indirect Economic Impacts</td>
      <td>203-02</td>
      <td>Significant indirect economic impacts</td>
      <td>NaN</td>
      <td>Treasury Policy</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>The treasury function, co-ordinated within Pro Medicus Limited, is limited to maximising return on surplus funds, subject to conservative investment risk exposure, and managing currency risk. The treasury function operates within policies set by the Board, which ensures that management's actions align with Board policy.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>5</td>
      <td>NaN</td>
      <td>Treasury Function, Surplus Funds, Financial</td>
      <td>8.0</td>
      <td>G</td>
      <td>10.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>203.0</td>
      <td>Indirect Economic Impacts</td>
      <td>203-02</td>
      <td>Significant indirect economic impacts</td>
      <td>The threat of new entrants to the market and the impact on the revenue base is managed and mitigated through long-term contracts, continuous product development, proactive customer engagement to determine needs and requirements and offering additional products to customers to add value.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>203.0</td>
      <td>Indirect Economic Impacts</td>
      <td>203-02</td>
      <td>Significant indirect economic impacts</td>
      <td>The threat of losing critical customers due to non-performance, non-compliance with Service Level Agreements (SLAs) or competition is managed and mitigated through regular reporting on crucial client satisfaction and assisted by automation of performance analysis of customer software.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>204.0</td>
      <td>Procurement Practices</td>
      <td>204-01</td>
      <td>Proportion of spending on local suppliers</td>
      <td>Our suppliers are located in the same country and regions as our offices, and we generally only go within these regions for supplier requirements.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>3</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Modern slavery statement</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>205.0</td>
      <td>Anti-corruption</td>
      <td>205-01</td>
      <td>Operations assessed for risks related to corruption</td>
      <td>Your work includes actual and potential clients, customers, suppliers, distributors, business contacts, agents, advisers, government and public bodies, including their advisors, representatives and officials, politicians and political parties.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>1</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Anti-bribery and corruption policy</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>205.0</td>
      <td>Anti-corruption</td>
      <td>205-02</td>
      <td>Communication and training about anti-corruption policies and procedures</td>
      <td>NaN</td>
      <td>Anti-Bribery and Corruption Policy</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>We are committed to directors, officers, employees, contractors, and consultants conducting themselves according to the highest standards of ethical conduct, including zero tolerance for bribery and corruption. To this end, we have adopted an Anti-Bribery and Corruption Policy, which is part of our risk management framework and underpinned by our mission. The policy applies to all our operations worldwide and employees (permanent, fixed term or temporary), contractors, consultants, secondees and directors.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17</td>
      <td>NaN</td>
      <td>Ethical Conduct, Anti-Bribery Policy, Standard</td>
      <td>16.0</td>
      <td>S</td>
      <td>16.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>205.0</td>
      <td>Anti-corruption</td>
      <td>205-03</td>
      <td>Confirmed incidents of corruption and actions taken</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>206.0</td>
      <td>Anti-competitive Behavior</td>
      <td>206-01</td>
      <td>Legal actions for anti-competitive behavior, anti-trust, and monopoly practices</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>207.0</td>
      <td>Tax</td>
      <td>207-01</td>
      <td>Approach to tax</td>
      <td>Pro Medicus Limited and its wholly-owned Australian-controlled entities implemented the tax consolidation legislation as of 1 July 2009. Members of the tax consolidated group have entered into a tax funding agreement.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>53</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>207.0</td>
      <td>Tax</td>
      <td>207-02</td>
      <td>Tax governance, control, and risk management</td>
      <td>As a result of the ATO's program of routine and regular tax audits, the Group anticipates that ATO audits may occur in the future. The Group is similarly subject to routine tax audits in certain overseas jurisdictions.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>72</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>207.0</td>
      <td>Tax</td>
      <td>207-03</td>
      <td>Stakeholder engagement and management of concerns related to tax</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>207.0</td>
      <td>Tax</td>
      <td>207-04</td>
      <td>Country-by-country reporting</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>301.0</td>
      <td>Materials</td>
      <td>301-01</td>
      <td>Materials used by weight or volume</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>301.0</td>
      <td>Materials</td>
      <td>301-02</td>
      <td>Recycled input materials used</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>301.0</td>
      <td>Materials</td>
      <td>301-03</td>
      <td>Reclaimed products and thei packaging materials</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>302.0</td>
      <td>Energy</td>
      <td>302-01</td>
      <td>Energy consumption within the organization</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>22</td>
      <td>NaN</td>
      <td>Energy, Efficiency, Renewable Energy,</td>
      <td>7.0</td>
      <td>E</td>
      <td>7.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>302.0</td>
      <td>Energy</td>
      <td>302-02</td>
      <td>Energy consumption outside of the organization</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>302.0</td>
      <td>Energy</td>
      <td>302-03</td>
      <td>Energy intensity</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>302.0</td>
      <td>Energy</td>
      <td>302-04</td>
      <td>Reduction of energy consumption</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>302.0</td>
      <td>Energy</td>
      <td>302-05</td>
      <td>Reductions in energy requirements of products and services</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>303.0</td>
      <td>Water and Effluents</td>
      <td>303-01</td>
      <td>Interactions with water as a shared resource</td>
      <td>Pro Medicus recognises the importance of promoting sustainable water management practices. Water scarcity is increasingly affecting more populations worldwide. Pro Medicus monitors and reports water consumption, intending to reduce our environmental impact and increase efficient water management practices.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>23</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>303.0</td>
      <td>Water and Effluents</td>
      <td>303-02</td>
      <td>Management of water discharge-related impacts</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>303.0</td>
      <td>Water and Effluents</td>
      <td>303-03</td>
      <td>Water withdrawal</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>303.0</td>
      <td>Water and Effluents</td>
      <td>303-04</td>
      <td>Water discharge</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>303.0</td>
      <td>Water and Effluents</td>
      <td>303-05</td>
      <td>Water consumption</td>
      <td>730.4 KL</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>23</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>304.0</td>
      <td>Biodiversity</td>
      <td>304-01</td>
      <td>Operational sites owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>304.0</td>
      <td>Biodiversity</td>
      <td>304-02</td>
      <td>Significant impacts of activities, produces, and services on biodiversity</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>304.0</td>
      <td>Biodiversity</td>
      <td>304-03</td>
      <td>Habitats protected or restored</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>304.0</td>
      <td>Biodiversity</td>
      <td>304-04</td>
      <td>IUCN Red List species and national conversation list species with habitats in areas affected by operations</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>305.0</td>
      <td>Emissions</td>
      <td>305-01</td>
      <td>Direct (Scope 1) GHG emissions</td>
      <td>1.9 tCO2e</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>23</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>305.0</td>
      <td>Emissions</td>
      <td>305-02</td>
      <td>Energy indirect (Scope 2) GHG emissions</td>
      <td>96,7 tCO2e</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>23</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>305.0</td>
      <td>Emissions</td>
      <td>305-03</td>
      <td>Other indirect (Scope 3) GHG emissions</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>305.0</td>
      <td>Emissions</td>
      <td>305-04</td>
      <td>GHG emissions intensity</td>
      <td>NaN</td>
      <td>Comprehensive carbon footprint assessment</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Determine our current greenhouse gas emissions by conducting a comprehensive carbon footprint assessment, considering emissions from energy consumption, transportation, waste generation, and those within the Group's supply chain.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>22</td>
      <td>NaN</td>
      <td>Greenhouse Gas, Carbon Footprint, Assessment</td>
      <td>13.0</td>
      <td>E</td>
      <td>13.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>305.0</td>
      <td>Emissions</td>
      <td>305-04</td>
      <td>GHG emissions intensity</td>
      <td>NaN</td>
      <td>Emissions reduction strategy</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>We establish achievable reduction targets for our Company's emissions. We aim to reduce emissions through energy efficiency measures, renewable energy adoption, and process optimisation.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>22</td>
      <td>NaN</td>
      <td>Reduction Targets, Emission Reduction, Efficiency</td>
      <td>13.0</td>
      <td>E</td>
      <td>13.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>305.0</td>
      <td>Emissions</td>
      <td>305-05</td>
      <td>Reduction of GHG emissions</td>
      <td>NaN</td>
      <td>Carbon neutral</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Being carbon neutral is an ongoing process, and we will continually evaluate and adjust our choices of emissions to minimise our environmental impact. Regularly track and report the Group's progress towards carbon neutrality.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>22</td>
      <td>NaN</td>
      <td>Carbon Neutral, Emission Minimisation, Environmental Impact</td>
      <td>13.0</td>
      <td>E</td>
      <td>13.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>305.0</td>
      <td>Emissions</td>
      <td>305-05</td>
      <td>Reduction of GHG emissions</td>
      <td>NaN</td>
      <td>GHG methodology</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>The GHG emissions have been prepared by Pro Medicus's GHG Inventory Basis of Preparation, which references the World Business Council for Sustainable Development Greenhouse Gas Protocol. The methodology for energy and emission factors related to the international offices is sourced from Australia's National Greenhouse Accounts (NGA), the German Environmental Federal Office and the US Environmental Protection Agency (EPA).</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>23</td>
      <td>NaN</td>
      <td>GHG Emissions, Inventory, Preparation</td>
      <td>13.0</td>
      <td>E</td>
      <td>13.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>305.0</td>
      <td>Emissions</td>
      <td>305-06</td>
      <td>Emissions of ozone-depleting substances (ODS)</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>305.0</td>
      <td>Emissions</td>
      <td>305-07</td>
      <td>Nitrogen oxides (NOx), sulfur oxides (SOx), and other significant air emissions</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>306.0</td>
      <td>Waste</td>
      <td>306-01</td>
      <td>Waste generation and significant waste-related impacts</td>
      <td>Develop strategies to minimise waste generation and maximise recycling within the Company.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>22</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>306.0</td>
      <td>Waste</td>
      <td>306-02</td>
      <td>Management of significant waste-related impacts</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>306.0</td>
      <td>Waste</td>
      <td>306-03</td>
      <td>Waste generated</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>306.0</td>
      <td>Waste</td>
      <td>306-04</td>
      <td>Waste diverted from disposal</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>306.0</td>
      <td>Waste</td>
      <td>306-05</td>
      <td>Waste directed to disposal</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>307.0</td>
      <td>Environmental Compliance</td>
      <td>307-01</td>
      <td>Non-compliance with environmental laws and regulations</td>
      <td>The Group has no significant identified risks about environmental regulations currently in force. There have been no known breaches of any rules by the Group.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>308.0</td>
      <td>Supplier Environmental Assessment</td>
      <td>308-01</td>
      <td>New suppliers that were screened using environmental criteria</td>
      <td>We trade only with recognised, reputable and credit-worthy third parties and have long-standing relationships with our suppliers that last several years or more. We currently do not have any joint venture arrangements and have minimal change in our supplier list from year to year, domestically and in our overseas subsidiaries.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>3</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>308.0</td>
      <td>Supplier Environmental Assessment</td>
      <td>308-02</td>
      <td>Negative environmental impacts in the supply chain and actions taken</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>401.0</td>
      <td>Employment</td>
      <td>401-01</td>
      <td>New employee hires and employee turnover</td>
      <td>NaN</td>
      <td>Employment Engagement Survey</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Our people are our most important asset, and the engagement survey lets us hear from them and identify areas to improve in future.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21, 22</td>
      <td>NaN</td>
      <td>Engagement Survey, Employee Feedback, People</td>
      <td>8.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>401.0</td>
      <td>Employment</td>
      <td>401-01</td>
      <td>New employee hires and employee turnover</td>
      <td>NaN</td>
      <td>Workforce Future Proofing</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Our succession planning framework helps us identify and develop talent who can move into leadership roles when they become vacant. It will ensure the Company maintains its productivity and thrives as leadership changes.\t</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21</td>
      <td>NaN</td>
      <td>Succession Planning, Talent Development, Employees</td>
      <td>8.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>401.0</td>
      <td>Employment</td>
      <td>401-01</td>
      <td>New employee hires and employee turnover</td>
      <td>NaN</td>
      <td>Employee loyalty and retention</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Employees who feel valued and supported are likelier to remain loyal to the Company. Reducing turnover saves recruitment and training costs and fosters continuity, stability, and institutional knowledge, contributing to sustainability.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21</td>
      <td>NaN</td>
      <td>Employee Retention, Turnover Reduction, Loyalty</td>
      <td>8.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>401.0</td>
      <td>Employment</td>
      <td>401-02</td>
      <td>Benefits provided to full-time employees that are not provided to temporary or part-time employees</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>401.0</td>
      <td>Employment</td>
      <td>401-03</td>
      <td>Parental leave</td>
      <td>Annual leave, sick leave, and Long service leave</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>62</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>402.0</td>
      <td>Labor/Management Relations</td>
      <td>402-01</td>
      <td>Minimum notice periods regarding operational changes</td>
      <td>The Group may terminate the Executive's employment agreement by providing three months' written notice or payment instead of the notice period (based on the fixed component of the Executive's remuneration). The Group may terminate the contract without notice if serious misconduct has occurred.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>35</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-01</td>
      <td>Occupation health and safety management system</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-02</td>
      <td>Hazard identification, risk assessment, and incident investigation</td>
      <td>The Committee's primary risk management responsibility is to monitor and review the Company's risk management framework at least annually to assess whether it is sound and is operating by the nature and extent of the acceptable levels of risk determined by the Board and report to the Board on the results of those assessments.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>4</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Audit and Risk Charter</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-03</td>
      <td>Occupational health services</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-04</td>
      <td>Worker participation, consultation, and communication on occupational health and safety</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-05</td>
      <td>Worker training on occupational health and safety</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-06</td>
      <td>Promotion of worker health</td>
      <td>NaN</td>
      <td>Work-life balance and well-being promotion</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Promote a healthy work-life balance by offering flexible work arrangements, wellness programs, and other initiatives that support physical and mental well-being.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21</td>
      <td>NaN</td>
      <td>Work-Life Balance, Wellness Programs, Workforce</td>
      <td>3.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-06</td>
      <td>Promotion of worker health</td>
      <td>NaN</td>
      <td>Productivity and efficiency approach</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>A satisfied workforce tends to be more productive and efficient. By prioritising the well-being of our staff, providing the necessary resources, and fostering a healthy work-life balance, we enhance productivity while reducing stress and burnout, ultimately contributing to the long-term sustainability of the business.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21</td>
      <td>NaN</td>
      <td>Workforce Satisfaction, Productivity, Wellbeing</td>
      <td>3.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-07</td>
      <td>Prevention and mitigation of occupational health and safety impacts directly linked by business relationships</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-08</td>
      <td>Workers covered by an occupational health and safety management system</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-09</td>
      <td>Work-related injuries</td>
      <td>Pro Medicus maintains a robust health and safety record and has zero workplace injuries.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>22</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>403.0</td>
      <td>Occupational Health and Safety</td>
      <td>403-10</td>
      <td>Work-related ill health</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>404.0</td>
      <td>Training and Education</td>
      <td>404-01</td>
      <td>Average hours of training per year per employee</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>404.0</td>
      <td>Training and Education</td>
      <td>404-02</td>
      <td>Programs for upgrading employee skills and transition assistance programs</td>
      <td>NaN</td>
      <td>Career Development Framework</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>This program provides training opportunities and skill-building initiatives to empower our staff to grow personally and professionally.\t</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21</td>
      <td>NaN</td>
      <td>Training, Skill Building, Empowerment</td>
      <td>4.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>404.0</td>
      <td>Training and Education</td>
      <td>404-03</td>
      <td>Percentage of employees receiving regular performance and career development reviews</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>405.0</td>
      <td>Diversity and Equal Opportunity</td>
      <td>405-01</td>
      <td>Diversity of governance bodies and employees</td>
      <td>NaN</td>
      <td>Diversity, Equity and Inclusion Policy (DEI)</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>During the year, we also updated our Diversity, Equity and Inclusion Policy (DEI), which was approved and endorsed by our Board. It forms the basis for our global DEI strategy and provides a framework to achieve the Company's diversity goals.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>21, 22</td>
      <td>NaN</td>
      <td>Diversity, Equity, Inclusion Policy</td>
      <td>5.0</td>
      <td>S</td>
      <td>10.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>405.0</td>
      <td>Diversity and Equal Opportunity</td>
      <td>405-02</td>
      <td>Ratio of basic salary and remuneration of women to men</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>406.0</td>
      <td>Non-discrimination</td>
      <td>406-01</td>
      <td>Incidents of discrimination and corrective actions taken</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>407.0</td>
      <td>Freedom of Association and Collective Bargaining</td>
      <td>407-01</td>
      <td>Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk</td>
      <td>NaN</td>
      <td>Due diligence</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>In preparing our first Statement, we mapped our supply chain. We engaged a representative sample of suppliers across industries, products, services, and geographies – focusing on those at a higher risk of modern slavery – to conduct due diligence. It involved requesting information from the supplier via a questionnaire on their human rights practices and supply chain.\t</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>4</td>
      <td>Supply Chain, Due Diligence, Human Rights</td>
      <td>8.0</td>
      <td>S</td>
      <td>8.0</td>
      <td>Modern slavery statement</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>408.0</td>
      <td>Child Labor</td>
      <td>408-01</td>
      <td>Operations and suppliers at significant risk for incidents of child labor</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>409.0</td>
      <td>Forced or Compulsory Labor</td>
      <td>409-01</td>
      <td>Operations and suppliers ar significant risk for incidents of forced or compulsory labor</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>410.0</td>
      <td>Security Practices</td>
      <td>410-01</td>
      <td>Security personnel trained in human rights policies or procedures</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>411.0</td>
      <td>Rights of Indigenous Peoples</td>
      <td>411-01</td>
      <td>Incidents of violations involving rights of indigenous peoples</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>412.0</td>
      <td>Human Rights Assessment</td>
      <td>412-01</td>
      <td>Operations that have been subject to human rights reviews or impacts assessments</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>412.0</td>
      <td>Human Rights Assessment</td>
      <td>412-02</td>
      <td>Employee training on human rights policies or procedures</td>
      <td>Level of understanding amongst staff: we will track training completion rates and awareness of modern slavery risk among staff</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>5</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Modern slavery statement</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>412.0</td>
      <td>Human Rights Assessment</td>
      <td>412-03</td>
      <td>Significant investment agreements and contracts that include human rights clauses or that underwent human rights screening</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>413.0</td>
      <td>Local Communities</td>
      <td>413-01</td>
      <td>Operations with local community engagement, impact assessments, and development programs</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>413.0</td>
      <td>Local Communities</td>
      <td>413-02</td>
      <td>Operations with significant actual and potential negative impacts on local communities</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>414.0</td>
      <td>Supplier Social Assessment</td>
      <td>414-01</td>
      <td>New suppliers that were screened using social criteria</td>
      <td>We trade only with recognised, reputable and credit-worthy third parties and have long-standing relationships with our suppliers that last several years or more. We currently do not have any joint venture arrangements and have minimal change in our supplier list from year to year, domestically and in our overseas subsidiaries.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>3</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Modern slavery statement</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>414.0</td>
      <td>Supplier Social Assessment</td>
      <td>414-02</td>
      <td>Negative social impacts in the supply chain and actions taken</td>
      <td>Overall, however, the risk that Pro Medicus or our supply chain would cause, contribute to or be directly linked to modern slavery is considered low.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>4</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>415.0</td>
      <td>Public Policy</td>
      <td>415-01</td>
      <td>Political contributions</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>416.0</td>
      <td>Customer Health and Safety</td>
      <td>416-01</td>
      <td>Assessment of the health and safety impacts of product and service categories</td>
      <td>NaN</td>
      <td>Patient Safety</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>AI algorithms should undergo rigorous testing and validation to ensure their accuracy and reliability in medical diagnosis, treatment planning, and decision-making. They should be designed to minimise the risk of errors or adverse outcomes.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>23</td>
      <td>NaN</td>
      <td>AI Algorithms, Testing, Validation</td>
      <td>3.0</td>
      <td>E</td>
      <td>3.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>416.0</td>
      <td>Customer Health and Safety</td>
      <td>416-01</td>
      <td>Assessment of the health and safety impacts of product and service categories</td>
      <td>NaN</td>
      <td>Subjectivity Mitigation</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Developers should strive to minimise biases in AI algorithms, ensuring they do not disproportionately favour or discriminate against any specific group of patients. Regular monitoring and auditing of AI systems can help identify and address potential biases.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>23</td>
      <td>NaN</td>
      <td>Bias Minimisation, AI Algorithms, Audit</td>
      <td>3.0</td>
      <td>E</td>
      <td>3.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>416.0</td>
      <td>Customer Health and Safety</td>
      <td>416-01</td>
      <td>Assessment of the health and safety impacts of product and service categories</td>
      <td>NaN</td>
      <td>Regulatory Compliance</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Medical software incorporating AI should adhere to relevant regulatory guidelines and standards. Compliance with regulatory frameworks, such as FDA (US Food and Drug Administration) regulations, is essential to ensure the safety and effectiveness of AI-powered medical software.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>23</td>
      <td>NaN</td>
      <td>Regulatory Compliance, Medical Software, FDA</td>
      <td>3.0</td>
      <td>E</td>
      <td>3.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>416.0</td>
      <td>Customer Health and Safety</td>
      <td>416-02</td>
      <td>Incidents of non-compliance concerning the health and safety impacts of products and services</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>417.0</td>
      <td>Marketing and Labeling</td>
      <td>417-01</td>
      <td>Requirements for product and service information and labeling</td>
      <td>Promoting responsible AI in medical software requires collaboration among software developers, healthcare providers, regulatory bodies, and other stakeholders. Pro Medicus must strike a balance between harnessing the potential of AI in improving healthcare outcomes while upholding ethical standards and patient safety.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>23</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>417.0</td>
      <td>Marketing and Labeling</td>
      <td>417-02</td>
      <td>Incidents of non-compliance concerning product and service information and labeling</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>417.0</td>
      <td>Marketing and Labeling</td>
      <td>417-03</td>
      <td>Incidents of non-compliance concerning marketing communications</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>418.0</td>
      <td>Customer Privacy</td>
      <td>418-01</td>
      <td>Substantiated complaints concerning breaches of customer privacy and losses of customer data</td>
      <td>NaN</td>
      <td>Data Privacy and Security Approach</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>Medical software should adhere to strict data protection standards, ensuring patient data is collected, stored, and processed securely. Compliance with privacy regulations, such as HIPAA (Health Insurance Portability and Accountability Act), is crucial.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17, 23</td>
      <td>NaN</td>
      <td>Data Protection, Privacy Regulations, Compliance</td>
      <td>3.0</td>
      <td>E</td>
      <td>3.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>418.0</td>
      <td>Customer Privacy</td>
      <td>418-01</td>
      <td>Substantiated complaints concerning breaches of customer privacy and losses of customer data</td>
      <td>NaN</td>
      <td>Privacy Statement</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>We have published a Privacy Statement, which ensures compliance with privacy laws where the Company operates. We have implemented various systems and processes internally to manage privacy, ensure compliance, and mitigate risks.</td>
      <td></td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17</td>
      <td>18</td>
      <td>Privacy Statement, Compliance, Risk Mitigation</td>
      <td>3.0</td>
      <td>E</td>
      <td>3.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>418.0</td>
      <td>Customer Privacy</td>
      <td>418-01</td>
      <td>Substantiated complaints concerning breaches of customer privacy and losses of customer data</td>
      <td>The risk of transgressing others' IP and the risk of IP being lost due to theft, copying by third parties or a rogue employee has been managed and mitigated through insurance, agreements, the ownership of critical patents and active surveillance. Should the likelihood of an inadvertent IP transgression arise, the Company can change and update product software to avoid any continuing patent breaches.</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>17</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>419.0</td>
      <td>Socioeconomic Compliance</td>
      <td>419-01</td>
      <td>Non-compliance with laws and regulations in the social and economical area</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NO DISCLOSURE</td>
      <td>Pro Medicus</td>
      <td>2023.0</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>NaN</td>
      <td>Total disclosure</td>
      <td>61</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>NaN</td>
      <td>Total no of reported disclosure over maximum disclosure (source:GRI index)</td>
      <td>61/122</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>NaN</td>
      <td>Average completion rate</td>
      <td>0.5</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>NaN</td>
      <td>NaN</td>
      <td>Maximum disclosure</td>
      <td>122</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
  </tbody>
</table>